Monod Bio Expands Board with Robert J. Bujarski's Appointment as Director Monod Bio has appointed Robert J. Bujarski to its Board of Directors, enhancing its mission in computational protein design and diagnostics.

Monod Bio Expands Board with Robert J. Bujarski's Appointment as Director #United_States #Seattle #Monod_Bio #Robert_Bujarski #NovoBody

Monod Bio Secures Funding for Groundbreaking Preeclampsia Diagnostic Utilizing AI Technology Monod Bio has been awarded a $750,000 grant to create an innovative diagnostic test for preeclampsia using AI-designed proteins, aiming to enhance maternal health in low-resource areas.

Monod Bio Secures Funding for Groundbreaking Preeclampsia Diagnostic Utilizing AI Technology #USA #Seattle #AI_Technology #preeclampsia #Monod_Bio

Monod Bio Strengthens Its Leadership by Appointing Timothy I. Still as Executive Chairman Monod Bio has appointed Timothy I. Still as its new Executive Chairman, significantly enhancing its leadership team and indicating a strategic growth phase.

Monod Bio Strengthens Its Leadership by Appointing Timothy I. Still as Executive Chairman #United_States #Seattle #Protein_Design #Monod_Bio #Timothy_Still

Monod Bio Secures $1.5 Million Grant for Groundbreaking TB Diagnostics Innovation Monod Bio has received a $1.5 million grant to develop NovoBodies™, aiming at enhancing tuberculosis diagnostics in low-resource areas.

Monod Bio Secures $1.5 Million Grant for Groundbreaking TB Diagnostics Innovation #USA #Seattle #Tuberculosis #Monod_Bio #NovoBodies